Updated Jul 16, 2026
White William Richard has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $679K.
William Richard White is a corporate executive known for his role as Chief Financial Officer at Akero Therapeutics, Inc. and Disc Medicine, Inc. He has been involved in various SEC filings related to these companies.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-09 | AKRO | Akero Therapeutics, Inc. | D — Derivative transaction | 47.6K | — | |
| 2025-12-09 | AKRO | Akero Therapeutics, Inc. | D — Derivative transaction | 10.2K | — | |
| 2025-09-11 | AKRO | Akero Therapeutics, Inc. | S — Open-market sale | 659 | $43.02 | $28K |
| 2025-06-30 | AKRO | Akero Therapeutics, Inc. | A — Grant or award | 890 | $23.87 | $21K |
| 2024-12-18 | AKRO | Akero Therapeutics, Inc. | A — Grant or award | 24.3K | $0.00 | |
| 2024-12-12 | AKRO | Akero Therapeutics, Inc. | S — Open-market sale | 2.8K | $30.79 | $87K |
| 2024-12-04 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 173 | $65.33 | $11K |
| 2024-12-04 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 1.8K | $64.58 | $114K |
| 2024-12-04 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 22 | $63.49 | $1K |
| 2024-12-04 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 201 | $9.86 | $2K |
| 2024-12-04 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 1.8K | $2.65 | $5K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 5.3K | $58.94 | $315K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 1.8K | $57.59 | $103K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 7.1K | $45.69 | $326K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 129 | $46.75 | $6K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 72 | $45.68 | $3K |
| 2024-11-05 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 201 | $9.86 | $2K |
| 2024-10-03 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 79 | $52.53 | $4K |
| 2024-10-03 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 50 | $51.51 | $3K |
| 2024-10-03 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 40 | $50.45 | $2K |
William Richard White is a corporate executive known for his role as Chief Financial Officer at Akero Therapeutics, Inc. and Disc Medicine, Inc. He has been involved in various SEC filings related to these companies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 13 open-market sales ($679K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live White William Richard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.